Deborah EGEA 医师
泌尿科医师
其他作者: Debora Egea, M.D. Affiliation: Department of Urology, San Isidro Central Hospital “Melchor Angel Posse”, Buenos Aires, Argentina.
Elevalift: a novel, office-based, non-surgica laser scrotoplasty for scrotal laxity - the first clinical experience
Objectives: To disseminate and validate, before the international aesthetic surgery and aesthetic medicine community, the results and multicenter protocol of Elevalift for scrotal lifting due to hyperlaxity; to seek expert feedback, promote standardized adoption of the technique, and foster multicenter collaborations and future research to improve patient safety and outcomes.
Introduction: Scrotal laxity is a common aesthetic and functional concern for which surgical scrotoplasty has been the traditional standard of care. However, surgery is associated with significant downtime, scarring, and potential complications. There is a growing demand for minimally invasive, office-based alternatives. This study introduces and evaluates Elevalift, a novel protocol using a subdermal diode laser for non-surgical scrotal skin tightening.
Materials / method: We report the first-in-world clinical experience, a prospective case series conducted at the San Isidro Central Hospital, Argentina, following approval from the Institutional Bioethics Committee and obtaining written informed consent from all participants. Five male patients (ages 58-65) with scrotal skin laxity and ptosis were treated. The Elevalift protocol was performed using a 1470 nm diode laser (LASEmaR® 1500) with a subdermal RING ELX optical fiber. The procedure was performed in an outpatient setting under local anesthesia, delivering controlled thermal energy to induce collagen remode
Results: All five patients were treated successfully with no intraoperative or postoperative adverse events. The total energy delivered ranged from 100 J to 400 J depending on the case. Follow-up at one month demonstrated marked improvement in skin ptosis and redundancy, with high patient satisfaction reported in all cases. The procedure required minimal recovery time, allowing for an immediate return to daily activities.
Conclusion: The Elevalift protocol is an innovative, safe, and effective minimally invasive alternative to surgical scrotoplasty. This first clinical experience demonstrates its feasibility for achieving significant aesthetic and functional improvement in scrotal laxity with an excellent safety profile and high patient satisfaction. This technique represents a promising new frontier in male aesthetic urology.